SBT115301 + Placebo
Phase 1Completed 0 watching 0 views this week๐ค Quiet
25
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety
Conditions
Safety
Trial Timeline
Jul 25, 2022 โ Jan 3, 2024
NCT ID
NCT05388981About SBT115301 + Placebo
SBT115301 + Placebo is a phase 1 stage product being developed by Sonoma Pharmaceuticals for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT05388981. Target conditions include Safety.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05388981 | Phase 1 | Completed |
Competing Products
20 competing products in Safety